Peter G. Traber
2017 - Galectin Therapeutics
In 2017, Peter G. Traber earned a total compensation of $877.4K as Chief Executive Officer & President at Galectin Therapeutics, a 14% decrease compared to previous year.
Compensation breakdown
| Bonus | $299,492 |
|---|---|
| Salary | $512,500 |
| Other | $65,397 |
| Total | $877,389 |
Traber received $512.5K in salary, accounting for 58% of the total pay in 2017.
Traber also received $299.5K in bonus and $65.4K in other compensation.
Rankings
In 2017, Peter G. Traber's compensation ranked 9,601st out of 14,666 executives tracked by ExecPay. In other words, Traber earned more than 34.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,601 out of 14,666 | 35th |
Division Manufacturing | 3,695 out of 5,772 | 36th |
Major group Chemicals And Allied Products | 1,279 out of 2,075 | 38th |
Industry group Drugs | 1,029 out of 1,731 | 41st |
Industry Pharmaceutical Preparations | 809 out of 1,333 | 39th |
Source: SEC filing on April 11, 2018.
Traber's colleagues
We found two more compensation records of executives who worked with Peter G. Traber at Galectin Therapeutics in 2017.